Primary retroperitoneal choriocarcinoma with lung metastasis: Case report

Author:

Vekariya Ruta Gordhanbhai1,Kanhere Shubhada1

Affiliation:

1. HCG Cancer Hospital, Ahmedabad, Gujarat, India

Abstract

Extragonadal germ cell tumor with choriocarcinoma in males is a rare tumor. Usually, Choriocarcinoma occurs in the midline of the body, such as the retroperitoneum and mediastinum. The B-hCG is used for diagnosis and monitoring treatment response. It is an aggressive and highly metastatic tumor with poor outcome.A 24-year-old male patient was admitted in our hospital with abdominal pain that had progressively worsened over two months andwas associated with a weight loss of 7 Kg over 2 months. Patient had no significant medical, personal, and family histories.The ultrasound abdomen showed mild hepatosplenomegaly and hepatic hemangioma. A CT scan of the thorax and whole abdomen showed multiple bilateral lung lesions with areas of arterial phase hyperenhancement. The largest lesion measured 60 x 42 mm in the left basal lung, and abdominal images showed an 86 x 68 x 90 mm lobulated left para-aortic lesion in the infrarenal location.An excision of the right lower lobe lung with nodule was done, and the histopathological findings were consistent with those of a germ cell tumor with a component of choriocarcinoma.Tumor markers, particularly serum beta human chorionic gonadotropin (B-hCG) was significantly raised with level of 917950 mIU/mL. Other tumor markers done were Lactate dehydrogenase (LDH) - 725 U/L and Alpha feto protein (AFP) -0.762 IU/ml.Patient was diagnosed with a primary retroperitoneal choriocarcinoma with metastasis to lungs and was started on urgent inpatient chemotherapy.Extragonadal choriocarcinoma always has a late presentation when these bulky tumors cause compression symptoms and metastasize to other places. Diagnosis of extragonadal choriocarcinomas requires the exclusion of metastatsis from a primary tumor in the testes and distinguishing an extragonadal GCT from another poorly differentiated cancer via histopathological and immunohistochemical examination.

Publisher

IP Innovative Publication Pvt Ltd

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3